annual CFF:
-$734.80M-$416.20M(-130.63%)Summary
- As of today (May 29, 2025), DXCM annual cash flow from financing activities is -$734.80 million, with the most recent change of -$416.20 million (-130.63%) on December 31, 2024.
- During the last 3 years, DXCM annual CFF has fallen by -$745.20 million (-7165.38%).
- DXCM annual CFF is now -180.56% below its all-time high of $912.10 million, reached on December 31, 2020.
Performance
DXCM Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$12.50M+$14.10M(+881.25%)Summary
- As of today (May 29, 2025), DXCM quarterly cash flow from financing activities is $12.50 million, with the most recent change of +$14.10 million (+881.25%) on March 31, 2025.
- Over the past year, DXCM quarterly CFF has increased by +$7.80 million (+165.96%).
- DXCM quarterly CFF is now -98.67% below its all-time high of $939.50 million, reached on June 30, 2023.
Performance
DXCM quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$727.00M+$7.80M(+1.06%)Summary
- As of today (May 29, 2025), DXCM TTM cash flow from financing activities is -$727.00 million, with the most recent change of +$7.80 million (+1.06%) on March 31, 2025.
- Over the past year, DXCM TTM CFF has dropped by -$401.90 million (-123.62%).
- DXCM TTM CFF is now -179.16% below its all-time high of $918.40 million, reached on June 30, 2020.
Performance
DXCM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DXCM Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -130.6% | +166.0% | -123.6% |
3 y3 years | -7165.4% | +135.8% | -4979.2% |
5 y5 years | -6967.3% | +92.3% | -6010.6% |
DXCM Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -7165.4% | at low | -98.7% | +101.7% | -283.0% | +46.7% |
5 y | 5-year | -180.6% | at low | -98.7% | +101.7% | -179.2% | +46.7% |
alltime | all time | -180.6% | at low | -98.7% | +101.7% | -179.2% | +46.7% |
DXCM Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $12.50M(-881.3%) | -$727.00M(-1.1%) |
Dec 2024 | -$734.80M(+130.6%) | -$1.60M(-99.8%) | -$734.80M(-46.2%) |
Sep 2024 | - | -$736.50M(>+9900.0%) | -$1.37B(+7.8%) |
Jun 2024 | - | -$1.40M(-129.8%) | -$1.27B(+289.4%) |
Mar 2024 | - | $4.70M(-100.7%) | -$325.10M(+2.0%) |
Dec 2023 | -$318.60M(-42.3%) | -$631.90M(-0.9%) | -$318.60M(-202.0%) |
Sep 2023 | - | -$637.40M(-167.8%) | $312.30M(-21.4%) |
Jun 2023 | - | $939.50M(+8288.4%) | $397.20M(-172.7%) |
Mar 2023 | - | $11.20M(-1220.0%) | -$546.60M(-1.1%) |
Dec 2022 | -$552.50M(-5412.5%) | -$1.00M(-99.8%) | -$552.50M(+0.0%) |
Sep 2022 | - | -$552.50M(>+9900.0%) | -$552.30M(-5120.9%) |
Jun 2022 | - | -$4.30M(-181.1%) | $11.00M(-26.2%) |
Mar 2022 | - | $5.30M(-762.5%) | $14.90M(+43.3%) |
Dec 2021 | $10.40M(-98.9%) | -$800.00K(-107.4%) | $10.40M(+65.1%) |
Sep 2021 | - | $10.80M(-2800.0%) | $6.30M(>+9900.0%) |
Jun 2021 | - | -$400.00K(-150.0%) | $0.00(-100.0%) |
Mar 2021 | - | $800.00K(-116.3%) | $906.40M(-0.6%) |
Dec 2020 | $912.10M(+8424.3%) | -$4.90M(-208.9%) | $912.10M(-0.5%) |
Sep 2020 | - | $4.50M(-99.5%) | $916.90M(-0.2%) |
Jun 2020 | - | $906.00M(>+9900.0%) | $918.40M(+7366.7%) |
Mar 2020 | - | $6.50M(-6600.0%) | $12.30M(+15.0%) |
Dec 2019 | $10.70M(-98.5%) | -$100.00K(-101.7%) | $10.70M(-98.5%) |
Sep 2019 | - | $6.00M(-6100.0%) | $712.40M(+0.1%) |
Jun 2019 | - | -$100.00K(-102.0%) | $711.80M(+0.1%) |
Mar 2019 | - | $4.90M(-99.3%) | $711.10M(+0.1%) |
Dec 2018 | $710.40M(+78.0%) | $701.60M(>+9900.0%) | $710.40M(+7882.0%) |
Sep 2018 | - | $5.40M(-775.0%) | $8.90M(+14.1%) |
Jun 2018 | - | -$800.00K(-119.0%) | $7.80M(-97.6%) |
Mar 2018 | - | $4.20M(+4100.0%) | $323.00M(-19.1%) |
Dec 2017 | $399.10M(+4827.2%) | $100.00K(-97.7%) | $399.10M(-0.1%) |
Sep 2017 | - | $4.30M(-98.6%) | $399.50M(-0.2%) |
Jun 2017 | - | $314.40M(+291.5%) | $400.30M(+369.8%) |
Mar 2017 | - | $80.30M(>+9900.0%) | $85.20M(+951.9%) |
Dec 2016 | $8.10M(-51.8%) | $500.00K(-90.2%) | $8.10M(-17.3%) |
Sep 2016 | - | $5.10M(-828.6%) | $9.80M(-3.0%) |
Jun 2016 | - | -$700.00K(-121.9%) | $10.10M(-33.1%) |
Mar 2016 | - | $3.20M(+45.5%) | $15.10M(-10.1%) |
Dec 2015 | $16.80M(-22.9%) | $2.20M(-59.3%) | $16.80M(-13.8%) |
Sep 2015 | - | $5.40M(+25.6%) | $19.50M(-3.5%) |
Jun 2015 | - | $4.30M(-12.2%) | $20.20M(+15.4%) |
Mar 2015 | - | $4.90M(0.0%) | $17.50M(-19.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2014 | $21.80M(+84.7%) | $4.90M(-19.7%) | $21.80M(0.0%) |
Sep 2014 | - | $6.10M(+281.3%) | $21.80M(+23.9%) |
Jun 2014 | - | $1.60M(-82.6%) | $17.60M(-3.8%) |
Mar 2014 | - | $9.20M(+87.8%) | $18.30M(+55.1%) |
Dec 2013 | $11.80M(+15.7%) | $4.90M(+157.9%) | $11.80M(-16.9%) |
Sep 2013 | - | $1.90M(-17.4%) | $14.20M(+4.4%) |
Jun 2013 | - | $2.30M(-14.8%) | $13.60M(+15.3%) |
Mar 2013 | - | $2.70M(-63.0%) | $11.80M(+15.7%) |
Dec 2012 | $10.20M(-86.3%) | $7.30M(+461.5%) | $10.20M(+244.2%) |
Sep 2012 | - | $1.30M(+160.0%) | $2.96M(+13.0%) |
Jun 2012 | - | $500.00K(-54.5%) | $2.62M(-96.5%) |
Mar 2012 | - | $1.10M(+1646.0%) | $73.84M(-0.5%) |
Dec 2011 | $74.20M(+6.6%) | $63.00K(-93.4%) | $74.20M(-30.9%) |
Sep 2011 | - | $958.00K(-98.7%) | $107.35M(-0.6%) |
Jun 2011 | - | $71.72M(+4802.0%) | $108.02M(+188.2%) |
Mar 2011 | - | $1.46M(-95.6%) | $37.47M(-46.2%) |
Dec 2010 | $69.60M(+56.8%) | $33.21M(+1943.9%) | $69.60M(+92.1%) |
Sep 2010 | - | $1.63M(+38.7%) | $36.24M(+5.4%) |
Jun 2010 | - | $1.17M(-96.5%) | $34.39M(+5.1%) |
Mar 2010 | - | $33.59M(<-9900.0%) | $32.73M(-26.3%) |
Dec 2009 | $44.38M(+1536.4%) | -$146.00K(-35.4%) | $44.38M(+0.8%) |
Sep 2009 | - | -$226.00K(-54.0%) | $44.02M(-0.1%) |
Jun 2009 | - | -$491.00K(-101.1%) | $44.06M(-0.4%) |
Mar 2009 | - | $45.24M(-9094.4%) | $44.24M(+1531.4%) |
Dec 2008 | $2.71M(-94.2%) | -$503.00K(+171.9%) | $2.71M(-9.9%) |
Sep 2008 | - | -$185.00K(-40.3%) | $3.01M(-4.9%) |
Jun 2008 | - | -$310.00K(-108.4%) | $3.17M(+14.4%) |
Mar 2008 | - | $3.71M(-1918.6%) | $2.77M(-94.1%) |
Dec 2007 | $46.60M(-9.0%) | -$204.00K(+603.4%) | $46.60M(-1.2%) |
Sep 2007 | - | -$29.00K(-95.9%) | $47.19M(-3.1%) |
Jun 2007 | - | -$709.00K(-101.5%) | $48.69M(-50.4%) |
Mar 2007 | - | $47.54M(>+9900.0%) | $98.25M(+91.8%) |
Dec 2006 | $51.22M(+0.9%) | $384.00K(-73.9%) | $51.22M(+0.7%) |
Sep 2006 | - | $1.47M(-97.0%) | $50.85M(+3.0%) |
Jun 2006 | - | $48.86M(+9593.7%) | $49.35M(-4.1%) |
Mar 2006 | - | $504.00K(+2830.2%) | $51.46M(+1.4%) |
Dec 2005 | $50.74M(+137.3%) | $17.20K(-155.5%) | $50.74M(+0.0%) |
Sep 2005 | - | -$31.00K(-100.1%) | $50.72M(-0.1%) |
Jun 2005 | - | $50.97M(<-9900.0%) | $50.76M(<-9900.0%) |
Mar 2005 | - | -$213.20K | -$213.20K |
Dec 2004 | $21.38M(>+9900.0%) | - | - |
Dec 2003 | $33.40K | - | - |
FAQ
- What is DexCom annual cash flow from financing activities?
- What is the all time high annual CFF for DexCom?
- What is DexCom annual CFF year-on-year change?
- What is DexCom quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for DexCom?
- What is DexCom quarterly CFF year-on-year change?
- What is DexCom TTM cash flow from financing activities?
- What is the all time high TTM CFF for DexCom?
- What is DexCom TTM CFF year-on-year change?
What is DexCom annual cash flow from financing activities?
The current annual CFF of DXCM is -$734.80M
What is the all time high annual CFF for DexCom?
DexCom all-time high annual cash flow from financing activities is $912.10M
What is DexCom annual CFF year-on-year change?
Over the past year, DXCM annual cash flow from financing activities has changed by -$416.20M (-130.63%)
What is DexCom quarterly cash flow from financing activities?
The current quarterly CFF of DXCM is $12.50M
What is the all time high quarterly CFF for DexCom?
DexCom all-time high quarterly cash flow from financing activities is $939.50M
What is DexCom quarterly CFF year-on-year change?
Over the past year, DXCM quarterly cash flow from financing activities has changed by +$7.80M (+165.96%)
What is DexCom TTM cash flow from financing activities?
The current TTM CFF of DXCM is -$727.00M
What is the all time high TTM CFF for DexCom?
DexCom all-time high TTM cash flow from financing activities is $918.40M
What is DexCom TTM CFF year-on-year change?
Over the past year, DXCM TTM cash flow from financing activities has changed by -$401.90M (-123.62%)